Pierre Bourgeois

8.2k total citations
242 papers, 5.4k citations indexed

About

Pierre Bourgeois is a scholar working on Rheumatology, Surgery and Oncology. According to data from OpenAlex, Pierre Bourgeois has authored 242 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Rheumatology, 62 papers in Surgery and 54 papers in Oncology. Recurrent topics in Pierre Bourgeois's work include Systemic Lupus Erythematosus Research (26 papers), Lymphatic System and Diseases (23 papers) and Breast Cancer Treatment Studies (22 papers). Pierre Bourgeois is often cited by papers focused on Systemic Lupus Erythematosus Research (26 papers), Lymphatic System and Diseases (23 papers) and Breast Cancer Treatment Studies (22 papers). Pierre Bourgeois collaborates with scholars based in France, Belgium and United Kingdom. Pierre Bourgeois's co-authors include Bruno Fautrel, Sylvie Rozenberg, Frédérique Gandjbakhch, Violaine Foltz, Albert Leduc, Denis Larsimont, Fabien Etchepare, Serge Rozenberg, Gabriel Liberale and A C Koeger and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Pierre Bourgeois

226 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Bourgeois France 42 1.8k 1.5k 1.1k 828 712 242 5.4k
H. A. Bird United Kingdom 33 1.7k 1.0× 924 0.6× 458 0.4× 375 0.5× 458 0.6× 133 4.5k
Boulos Haraoui Canada 47 5.8k 3.2× 1.7k 1.2× 1.3k 1.2× 478 0.6× 1.5k 2.1× 196 8.5k
Martin Soubrier France 42 3.5k 2.0× 1.3k 0.9× 997 0.9× 424 0.5× 1.1k 1.5× 300 6.7k
W. Watson Buchanan United Kingdom 38 2.6k 1.4× 1.2k 0.8× 544 0.5× 354 0.4× 572 0.8× 219 6.3k
Jérémie Sellam France 44 4.3k 2.4× 1.2k 0.8× 651 0.6× 534 0.6× 1.2k 1.7× 201 7.2k
Louis Bessette Canada 35 2.4k 1.4× 1.5k 1.0× 827 0.7× 537 0.6× 891 1.3× 175 5.2k
Marissa Lassere Australia 38 4.2k 2.4× 1.1k 0.7× 1.2k 1.1× 277 0.3× 833 1.2× 122 5.9k
Kim Hørslev‐Petersen Denmark 39 2.8k 1.5× 538 0.4× 981 0.9× 451 0.5× 735 1.0× 194 4.6k
Ronald Brand Netherlands 52 648 0.4× 2.6k 1.7× 1.5k 1.4× 1.1k 1.4× 459 0.6× 156 9.0k
Roberto Caporali Italy 56 5.7k 3.2× 1.1k 0.8× 1.7k 1.6× 743 0.9× 2.2k 3.1× 450 10.4k

Countries citing papers authored by Pierre Bourgeois

Since Specialization
Citations

This map shows the geographic impact of Pierre Bourgeois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Bourgeois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Bourgeois more than expected).

Fields of papers citing papers by Pierre Bourgeois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Bourgeois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Bourgeois. The network helps show where Pierre Bourgeois may publish in the future.

Co-authorship network of co-authors of Pierre Bourgeois

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Bourgeois. A scholar is included among the top collaborators of Pierre Bourgeois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Bourgeois. Pierre Bourgeois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mármol, V. del, et al.. (2023). Indo-cyanine green administration to identify loss of lymph after axillary lymph node dissection. Frontiers in Oncology. 13. 1045495–1045495.
3.
Nogaret, Jean‐Marie, et al.. (2022). The Impact of Temporal Variation in ICG Administration on Axillary Node Identification During Reverse Mapping Procedures. Chirurgia. 117(3). 305–305. 2 indexed citations
4.
Liberale, Gabriel, Sophie Vankerckhove, Fikri Bouazza, et al.. (2020). Systemic Sentinel Lymph Node Detection Using Fluorescence Imaging After Indocyanine Green Intravenous Injection in Colorectal Cancer: Protocol for a Feasibility Study. JMIR Research Protocols. 9(8). e17976–e17976. 7 indexed citations
5.
Bourgeois, Pierre, et al.. (2019). Pancytopenia as a complication of radiotherapy and Iodine 131 treatment in a thyroid cancer. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 40(2). 89–92.
7.
Guyader, Olivier, Lionel Reynal, Sébastien Durand, et al.. (2013). Synthèse des Pêcheries de Guadeloupe 2010. Institutional Archive of Ifremer (French Research Institute for Exploitation of the Sea). 1 indexed citations
8.
Fautrel, Bruno, Mathilde Benhamou, Violaine Foltz, et al.. (2009). Early referral to the rheumatologist for early arthritis patients: evidence for suboptimal care. Results from the ESPOIR cohort. Lara D. Veeken. 49(1). 147–155. 24 indexed citations
9.
Belgrado, Jean-Paul, et al.. (2005). ELECTROMYOSTIMULATION COMBINED WITH INTERMITTENT PNEUMATIC COMPRESSION. The Journal of General Physiology. 15(45). 17–22. 1 indexed citations
10.
Nogaret, Jean‐Marie, Dina Hertens, Isabelle Veys, Pierre Bourgeois, & Denis Larsimont. (2002). Ganglion sentinelle et cancer invasif du sein: vers une nouvelle approche chirurgicale minimaliste.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 23(3).
11.
Fautrel, Bruno, G Le Moël, B. Saint-Marcoux, et al.. (2001). Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.. PubMed. 28(2). 322–9. 212 indexed citations
12.
Awada, Ahmad, Pierre Bourgeois, Nathalie Cornez, et al.. (1999). A clinical pharmacodynamic (Pd) and pharmacokinetic (Pk) phase I study of I.V. R101933, an inhibitor of MDR1 P-glycoprotein (PgP) given alone and in combination with Taxol in patients with solid tumors. Clinical Cancer Research. 3833. 1 indexed citations
13.
Bourgeois, Pierre, et al.. (1997). [Sacral nerve root cysts. Discussion on the mechanism of nerve root suffering. Apropos of 4 cases].. PubMed. 43(4). 237–44. 3 indexed citations
14.
Rozenberg, Serge & Pierre Bourgeois. (1994). [What remains of gout in 1993?].. PubMed. 44(2). 178–82. 1 indexed citations
15.
Paolozzi, L, G Delecoeuillerie, Pierre Bourgeois, et al.. (1994). A possible linkage of HLA-DRB haplotypes with Tiopronin intolerance in rheumatoid arthritis.. PubMed. 12(3). 249–54. 5 indexed citations
16.
Rozenberg, Serge, et al.. (1993). Manifestations rhumatologiques chez les transplantés cardiaques. Etude transversale de 365 patients.. 60(1). 10–15. 3 indexed citations
17.
Líénard, Danielle, et al.. (1990). Treatment of advanced angiosarcomas of the limbs by isolation perfusion. 3(2). 98–102. 3 indexed citations
18.
Bourgeois, Pierre. (1982). [Laennec and his times].. PubMed. 57(47-48). 2047–56. 1 indexed citations
19.
Kaplan, G, P Vinceneux, Pierre Bourgeois, & M F Kahn. (1977). [Gougerot-Sjögren syndrome, connective tissue diseases and autoimmune pathology].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 44(7-9). 471–8. 3 indexed citations
20.
Mf, Kahn, et al.. (1977). [Chondrodysplastic rheumatism. Apropos of 50 cases].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 128(11). 857–60. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026